Coquilla, Juvie .
HRN: 22-26-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2022
CEFUROXIME 500MG (TAB)
12/06/2022
12/13/2022
ORAL
500mg
BID
CS
Waiting Final Action
Indication: ProphylaxisEmpiric Then Culture-directed Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes